|
Volumn 320, Issue 9, 2018, Pages 867-868
|
Real-world evidence and real-world data for evaluating drug safety and effectiveness
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BLINATUMOMAB;
ACUTE LYMPHOBLASTIC LEUKEMIA;
AGE;
ATRIAL FIBRILLATION;
CEREBROVASCULAR ACCIDENT;
COMORBIDITY;
DISEASE SEVERITY;
DRUG APPROVAL;
DRUG COST;
DRUG DEVELOPMENT;
DRUG EFFICACY;
DRUG INDICATION;
DRUG RESEARCH;
DRUG RESPONSE;
DRUG SAFETY;
ELECTRONIC HEALTH RECORD;
EVIDENCE BASED PRACTICE;
FOOD AND DRUG ADMINISTRATION;
METHODOLOGY;
PATIENT PARTICIPATION;
PRIORITY JOURNAL;
REVIEW;
EVIDENCE BASED MEDICINE;
HUMAN;
INFORMATION PROCESSING;
LEGISLATION AND JURISPRUDENCE;
MEDICAL RESEARCH;
OBSERVATIONAL STUDY;
PROCEDURES;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
UNITED STATES;
BIOMEDICAL RESEARCH;
DATASETS AS TOPIC;
DRUG APPROVAL;
ELECTRONIC HEALTH RECORDS;
EVIDENCE-BASED MEDICINE;
HUMANS;
OBSERVATIONAL STUDIES AS TOPIC;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
EID: 85052708425
PISSN: 00987484
EISSN: 15383598
Source Type: Journal
DOI: 10.1001/jama.2018.10136 Document Type: Review |
Times cited : (301)
|
References (6)
|